미국 의약품용 파파인 공급업체 및 가격 — 마켓 오버뷰 2026

상위 제품

파파인

최종 업데이트

2026-08-23

서치 및 소싱 팀을 위한 핵심 요약

미국에 대한 샘플 수출 거래 2건이 요약되어 있습니다.
페이지 데이터 최종 업데이트일: 2026-08-23.

미국 내 의약품용 파파인 수출 공급업체 인텔리전스, 가격 추이 및 무역 흐름

미국의 의약품용 파파인에 대해 수출 파트너 기업 2개가 추적됩니다. Supply Chain Intelligence 회사 프로필 및 분석으로 수출업체 커버리지, 파트너 품질, 경로 우선순위를 검증하세요.

미국에서의 의약품용 파파인 수출 인텔리전스를 확인하세요. 샘플 공급업체 거래 2건, 월간 단가 범위, HS 코드 -의 파트너 국가 무역 흐름 패턴을 포함합니다.

스캐터 포인트는 전체 거래 데이터셋의 100.0%에서 샘플링되었습니다.

의약품용 파파인의 미국 샘플 수출 공급업체 거래 기록

미국의 의약품용 파파인 샘플 거래 2건에는 수출 가격과 공급업체 거래 패턴 벤치마킹을 위한 날짜, 원산지, 파트너 국가 맥락이 포함됩니다.

미국의 의약품용 파파인 샘플 거래 단가(일자별): 2025-10-31: 27.11 USD / kg, 2025-10-24: 26.83 USD / kg.

일자	신고 품목	단가	수출업체	수입업체
2025-10-31	SUP****** ********* ****** ** **** ****** ***** * * *******	27.11 USD / kg	(미국)	(코스타리카)
2025-10-24	SUP****** ********* ****** ** **** ****** ***** * * *******	26.83 USD / kg	(미국)	(코스타리카)

미국 내 상위 의약품용 파파인 수출 공급업체 및 기업

선도 수출업체 프로필을 검토하고 미국의 의약품용 파파인에 대해 추적되는 전체 수출 파트너 기업 2개와 비교하세요. Supply Chain Intelligence 회사 프로필 및 분석으로 소싱 및 수출 파트너를 더 빠르게 선별할 수 있습니다.

(미국)

최근 수출 거래: 2026-07-23

임직원 규모: 직원 101 - 500명

매출액: 매출 USD 50M - 100M

산업군: 식품 제조식품 포장식품 도매기타

밸류체인 역할: 유통 / 도매

(미국)

최근 수출 거래: 2026-07-23

임직원 규모: 직원 1000명 초과

산업군: 음료 제조식품 제조기타

밸류체인 역할: 식품 제조기타

미국 수출 파트너 커버리지

2개 기업

총 수출 파트너 기업 수는 미국의 의약품용 파파인 수출 네트워크 깊이를 보여주는 핵심 신호입니다.

수출업체와 수입업체는 공급망 인텔리전스 기업 프로필 및 분석을 열어 미국 내 의약품용 파파인 파트너 집중도, 공급 역량 시그널, 무역 관련성을 평가할 수 있습니다.

소싱 진단

미국산 의약품용 파파인, 우리도 들여올 수 있을까요?

필요한 스펙과 물량만 알려주세요. 실제로 소싱이 되는지, 어떤 원산지와 공급사가 맞는지 무료로 짚어드려요.

수출 진단

우리 의약품용 파파인, 이 미국 바이어들에게 팔 수 있을까요?

만드시는 제품만 알려주시면 됩니다. 지금 수출할 준비가 됐는지, 어느 시장이 맞는지 무료로 봐드려요.

가격 데이터

가려진 미국 의약품용 파파인 가격, 열어볼까요?

전체 가격 히스토리와 경쟁사 벤치마크를 열어드립니다. 어떤 숫자가 필요하신지만 말씀해 주시면 함께 살펴봐 드려요.

Classification

Product TypeIngredient

Product FormPowder (dry enzyme preparation)

Industry PositionFunctional enzyme ingredient (food processing aid and pharmaceutical-quality ingredient)

Market

Pharmaceutical-grade papain in the United States is primarily a regulated, downstream formulation and quality-driven market rather than a primary production origin. For food uses, papain is affirmed as a GRAS direct human food ingredient when used under current good manufacturing practice and meeting incorporated Food Chemicals Codex specifications. For pharmaceutical-quality use, buyers commonly reference USP–NF monograph expectations, including minimum enzyme activity specifications. Market access is therefore shaped more by documentation, conformance testing, and importer verification systems than by domestic agricultural seasonality.

Market RoleImport-dependent consumer and formulation market

Domestic RoleDownstream quality control testing, blending/standardization, repackaging, and distribution into food, dietary supplement, and pharmaceutical manufacturing channels

Market GrowthNot Mentioned

Specification

Physical Attributes

Permitted for food use as an enzyme preparation in either liquid or dry form (food-grade context)
Pharmaceutical-quality trade is commonly handled as a dry powder to support dosing and stability control (buyer practice varies)

Compositional Metrics

USP–NF monograph specifies papain contains not less than (NLT) 6000 Units/mg (enzyme activity standard)
Food-grade papain is required by regulation to meet incorporated Food Chemicals Codex specifications when used as a direct human food ingredient

Grades

Food-grade: FCC-aligned specifications referenced in 21 CFR 184.1585
Pharmaceutical-grade: USP–NF monograph conformance commonly required by regulated buyers

Packaging

Moisture-barrier, sealed packaging with lot identification and Certificate of Analysis (CoA)
Storage and handling controls focused on preventing moisture uptake and activity loss

Supply Chain

Value Chain

Latex collection from unripe papaya (origin countries) -> aqueous extraction/filtration or precipitation -> drying -> activity standardization (may include dilution to official standard) -> bulk packaging -> import -> U.S. receiving QC and documentation review -> distribution to food/dietary supplement/pharmaceutical manufacturers

Temperature

Maintain cool, dry storage conditions to protect enzyme activity and prevent caking/moisture-driven degradation

Atmosphere Control

Moisture control (sealed containers, humidity management) is typically more critical than oxygen control for preserving activity

Shelf Life

Shelf-life is sensitive to exposure to humidity and elevated temperatures; delays can trigger re-testing and potential lot rejection in regulated channels

Freight IntensityLow

Transport ModeMultimodal

Risks

Regulatory Compliance HighPharmaceutical-grade and regulated-channel buyers in the United States commonly require documented conformance to compendial/specification frameworks (e.g., USP–NF activity requirements) and robust quality documentation; nonconformance or documentation gaps can result in batch rejection, loss of approved-supplier status, and disruption of downstream manufacturing supply commitments.Implement a documented release program with CoA-to-spec verification (activity and identity), change-control notifications, and supplier qualification/audits aligned to the intended use (food vs pharmaceutical).

Regulatory Compliance MediumFood/ingredient shipments offered for import into the United States can be refused or delayed if Prior Notice is not submitted accurately and on time, creating delivery disruption and added storage/handling risk.Build a shipment-level compliance checklist to ensure Prior Notice data completeness, align broker/filing workflows, and keep contingency plans for holds and re-routing.

Worker Safety MediumPapain has been reported in the medical literature to cause occupational asthma and severe allergic reactions in exposed workers, which can trigger workplace health incidents and compliance issues for handlers of papain powder.Use closed handling where feasible, apply local exhaust ventilation and dust control, and enforce PPE and training for powdered enzyme handling.

Climate MediumUpstream papaya crop disease dynamics (notably papaya ringspot virus) can be highly disruptive to papaya production regions, creating supply tightness and price volatility for latex-derived enzyme inputs used to make papain.Diversify sourcing across origin countries/suppliers, maintain safety stocks for critical formulations, and monitor key origin-region crop disease alerts relevant to papaya.

Sustainability

Upstream agricultural supply risk from papaya crop disease pressure in origin countries (e.g., papaya ringspot virus), which can tighten crude latex availability and raise sourcing volatility

Labor & Social

Worker health risk: papain dust exposure has been associated in the literature with occupational sensitization, asthma, and severe allergic reactions; handling controls are important in warehouses and manufacturing environments

FAQ

Is papain permitted for use in food in the United States?Yes. FDA’s regulation at 21 CFR § 184.1585 affirms papain as generally recognized as safe (GRAS) for direct use in food when it meets the incorporated Food Chemicals Codex specifications and is used under current good manufacturing practice as an enzyme/processing aid/texturizer.

What activity specification is referenced for USP–NF papain used in pharmaceutical-quality contexts?The USP–NF monograph definition states that papain contains not less than (NLT) 6000 Units per milligram, and it describes the standardization concept for meeting the official activity standard.

What is a critical U.S. import compliance step for food-ingredient shipments of papain?FDA requires Prior Notice for food (including food ingredients) that is imported or offered for import into the United States, and inadequate Prior Notice can lead to refusal and holds at the port of entry.